ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)

News

Zura Bio (NASDAQ:ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Zura Bio (NASDAQ:ZURA) was downgraded by analysts at Wall Street Zen
Zura Bio (NASDAQ:ZURA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $10.00 price target on the stock.
Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates
Zura Bio (NASDAQ:ZURA) was upgraded by analysts at Wall Street Zen f
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com